[Influence on cell proliferation by small interfering RNA of Cyclin Y expression in laryngeal cancer cells]

Jun Tai1, Ai-Dong Li, Yuan-Sheng Rao

  • 1Beijing Key Laboratory for Pediatric Otolaryngology, Head and Neck Science, Beijing Pediatric Research Institute,Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.

Abstract

Insights

Lentivirus-mediated suppression of Cyclin Y (CCNY) significantly reduced laryngeal cancer cell proliferation and growth. This suggests CCNY targeting via lentivirus may offer a novel therapeutic strategy for laryngeal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Laryngeal cancer remains a significant health concern with limited treatment options.
  • Understanding the molecular mechanisms driving laryngeal cancer proliferation is crucial for developing targeted therapies.
  • Cyclin Y (CCNY) has been implicated in cell cycle regulation, but its role in laryngeal cancer is not fully elucidated.

Purpose of the Study:

  • To investigate the effect of lentivirus-mediated Cyclin Y (CCNY) gene silencing on the proliferation of laryngeal cancer cells in vitro.
  • To assess the potential of CCNY as a therapeutic target in laryngeal cancer.

Main Methods:

  • Construction of lentivirus vectors expressing short hairpin RNA (shRNA) targeting CCNY.
  • Infection of Hep-2 laryngeal cancer cells with CCNY-targeting or control lentiviruses.
  • Quantification of CCNY mRNA levels using Real-time PCR.
  • Assessment of cell proliferation and viability using MTT and colony formation assays.

Main Results:

  • Successful construction of lentiviruses for CCNY knockdown.
  • Significant reduction (over 75%) in CCNY mRNA expression in Hep-2 cells following lentiviral infection.
  • Marked decrease in Hep-2 cell viability and colony formation (up to 60%) after CCNY silencing.
  • Lentiviral infection demonstrated efficacy in downregulating CCNY in laryngeal cancer cells.

Conclusions:

  • Lentivirus-mediated suppression of CCNY expression effectively inhibits the proliferation and growth of laryngeal cancer cells.
  • Targeting CCNY using lentiviral delivery of shRNA represents a promising therapeutic approach for laryngeal cancer.
  • Further research into CCNY's role and lentiviral therapy is warranted for clinical application.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K